Perbedaan Diagnos Laboratorium Utama Tbk. dan Trimegah Karya Pratama Tbk.: Diagnos Laboratorium Utama Tbk. diperdagangkan di Rp224 (kapitalisasi pasar 310,75 M, volume 24 jam 963,6 rb), sedangkan Trimegah Karya Pratama Tbk. diperdagangkan di Rp136 (kapitalisasi pasar 268,02 M, volume 24 jam 36,96 jt). Perbedaan utamanya: Diagnos Laboratorium Utama Tbk. lebih besar dari sisi kapitalisasi pasar, dan Trimegah Karya Pratama Tbk. lebih aktif diperdagangkan (36,96 jt vs 963,6 rb). Mana yang lebih baik tergantung tujuan investasimu.
| DGNS | UVCR | |
|---|---|---|
Kapitalisasi Pasar | 310,75 M | 268,02 M |
Volume | 963,6 rb | 36,96 jt |
Lot | 9,64 rb | 369,56 rb |
Perputaran | 217,67 jt | 5,02 M |
Harga Rata-rata | 225,89 | 135,74 |
Nilai Transaksi | 217,67 jt | 5,02 M |
Harga Ekuilibrium Indikatif | 226 | 136 |
Volume Ekuilibrium Indikatif | 1 rb | 2,08 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Selengkapnya di halaman DGNS →PT Trimegah Karya Pratama Tbk (the Company) was established based on Notarial Deed No. 21 dated July 7, 2017 of Netty Maria Machdar, S.H. The Company started its commercial operations in 2018. The Company’s immediate parent company is PT Trimegah Sumber Mas, which was established and domiciled in Indonesia, while its ultimate Parent Company is PT Hutama Mulia Rajawali, which was established and domiciled in Indonesia.
Selengkapnya di halaman UVCR →